Skip to main content
. Author manuscript; available in PMC: 2010 Jun 5.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):545–553. doi: 10.1002/ajmg.b.30858

Table 1.

Summary of the number of participants with FXS taking different types of medication at the time of testing, by PPI% quartiles

Quartile (n) PPI Range No Medication SSRI/SNRI Antipsychotics Stimulants Anticonvulsants Sedatives Other Antidepressants
1 (11) −20.83-18.53 2 7 0 3 0 0 0
2 (10) 18.54-37.52 4 4 1 2 0 0 1
3 (11) 37.53-55.11 4 3 3 3 0 0 1
4 (10) 55.12-74.23 3 4 2 3 1 1 2
HHS Vulnerability Disclosure